TLIS

Talis Biomedical Corporation Common Stock
TLIS

Overview Fund Activity
Delisted

TLIS was delisted on the 30th of August, 2024.

Back to rankings

45 hedge funds and large institutions have $23.6M invested in Talis Biomedical Corporation Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 23 reducing their positions, and 8 closing their positions.

Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
23
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GC
1
Greenlight Capital
New York
$3.15M
2
PCM
2
Prelude Capital Management
New York
$362K
3
PPA
3
Parametric Portfolio Associates
Washington
$196K
4
BCM
4
Bridgeway Capital Management
Texas
$76K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$23K

Top Sellers

1
ACH
1
ArrowMark Colorado Holdings
Colorado
$5.27M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$10K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$864K
4
PP
4
PDT Partners
New York
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
EI
51
Ellevest Inc
New York
– – -41 Closed
Group One Trading
52
Group One Trading
Illinois
– – – –
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
Toronto Dominion Bank
54
Toronto Dominion Bank
Ontario, Canada
$0 2 – –
CAL
55
Capital Advisors Ltd
Ohio
$0 117 +117 New
1 2
3